Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Hawaiian Electric Industries (HE) Stock Is Getting Hammered

Hawaiian Electric Industries, Inc. (NYSE: HE) shares are trading lower by 23.8% to $9.04 Friday morning after Maui County filed a lawsuit against the company alleging a role in the Lahaina wildfires.
byHenry Khederian
August 25, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Hawaiian Electric Industries, Inc. (NYSE:HE) shares are trading lower by 23.8% to $9.04 Friday morning after Maui County filed a lawsuit against the company alleging a role in the Lahaina wildfires. The company also suspended its quarterly cash dividend on common stock.

In addition, HEI drew $170 million and Hawaiian Electric drew $200 million under their existing revolving unsecured credit facilities. The companies plan to “invest the cash proceeds in highly liquid short-term investments,” according to the SEC filing.

The recent plunge in shares propels the company’s stock toward levels not observed since October 1987.

The situation is exacerbated by mounting concerns over the company’s involvement in the Maui wildfires and recent reports by the Wall Street Journal suggesting discussions with restructuring advisory firms to tackle its mounting financial and legal challenges…Read More

According to data from Benzinga Pro, HE has a 52-week high of $43.71 and a 52-week low of $9.04.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

By Jelena Martinovic
February 14, 11:03 AM
Medical cannabis company cbdMD has reported financial results for its first quarter of fiscal 2024. Operating loss improved to $1.1m compared to $4.1m for the same period in the previous year. Gross profit was flat at around $3.5m, while operating expenses were $4.6m, down from $7.6m in the previous year. Total net sales declined to $5.37m from almost $6m in the corresponding prior-year period. Direct-to-consumer net sales represented 82.3% of total net sales, a decrease from 90% in Q1 2023. On 31 December 2023, cbdMD had total working capital of roughly $1.4m compared to approximately $3.4m on 30 September, with cash on hand dropping to roughly $1.5m from $1.8m over the same period. The Charlotte-based company recently struck a securities purchase agreement with five institutional investors to fund the national rollout of its ATRx Labs functional mushroom products, as well as launching the hempMD and ATRx Labs brands.

YCBD